The effect of tirilazad mesylate on infarct volume of patients with acute ischemic stroke.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 11781420.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The authors investigated whether the lack of effect of tirilazad on clinical outcome in patients with acute ischemic stroke is explained by failure of tirilazad to reduce infarct volume. Overall, tirilazad had no significant effect on infarct volume. In the subgroups of male patients and of those with a cortical infarct, tirilazad significantly reduced infarct volume. These effects were reduced to nonsignificant trends after adjustment for imbalances in baseline characteristics. In conclusion, early treatment of patients with tirilazad has no effect on infarct volume.
Medical subject headings
- Brain Ischemia
- Cerebral Infarction
- Neuroprotective Agents
- Pregnatrienes